This inventor holds 8 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: University of Michigan. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: Sunitha Nagrath: Innovator in Tumor Cell Detection
Introduction
Sunitha Nagrath is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of medical technology, particularly in the detection and capture of circulating tumor cells (CTCs). With a total of 8 patents to her name, her work is paving the way for advancements in cancer diagnostics.
Latest Patents
One of her latest patents is the "Indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells." This innovative apparatus is designed to capture CTCs from blood using a wearable device that receives fluid from the vasculature of a subject. The device includes a pump that adjusts the flow rate of blood and features a replaceable candidate cell capture module with microfluidic capture stages. This technology aims to enhance the efficiency of capturing candidate cells through antibodies and return the blood to the subject's vasculature.
Another notable patent is the "Functionalized graphene oxide system for detecting rare cells." This system includes a substrate with an extension that has functionalized graphene oxide, which interacts with bodily fluid samples to detect rare cells. The method outlined in this patent provides a novel approach to identifying rare cells, which can be crucial for various medical applications.
Career Highlights
Sunitha Nagrath is affiliated with the University of Michigan, where she continues her research and development in medical technologies. Her work has garnered attention for its potential impact on cancer treatment and diagnostics.
Collaborations
She has collaborated with notable colleagues, including Hyeun Joong Yoon and Eric Lin, to further her research initiatives and enhance the effectiveness of her inventions.
Conclusion
Sunitha Nagrath's innovative contributions to the field of medical technology, particularly in the detection of circulating tumor cells, highlight her role as a leading inventor. Her patents reflect a commitment to advancing cancer diagnostics and improving patient outcomes.